Skip to main content

Getting started on eversense cgm just got easier Existing Customers COVID-19 Update

Desktop Top header menu

PATIENTS
Resource Library

Eversense USA Eversense OUS

Getting started on eversense cgm just got easier Existing Customers COVID-19 Update

Existing Bridge Program users click here for program updates.

Main navigation

Why Eversense CGM?
Education & Resources
Become a Provider
Reimbursement
DMS LOGIN

Mobile Main Navigation

Why Eversense CGM?
EDUCATION & RESOURCES
BECOME A PROVIDER
REIMBURSEMENT
- Reimbursement
- Bridge Program
REQUEST INFO

Patient Website
Payer Website

Eversense USA Eversense OUS

Site Map

Paragraphs

Sitemap

SITE MAP

What is Eversense CGM?

Why Eversense CGM?

Sensor
Transmitter
Mobile App

EDUCATION & RESOURCES

Resource Library
Clinical Education
Peer to Peer Education
Grants & Donations
Get Support
Share Your Resources
FAQS

BECOME A PROVIDER

Training Program & Certification
Begin Learning
Register For Training

Bridge Program

Footer Menu

EULA
Privacy Policy
Legal
Safety Information

Selector Id

sitemap-page-content

Selector Class

sitemap-page-content

x

Right -Fixed Menu Home Page

Email
Become a provider

Footer top menu

Need more information or support?
844-SENSE4U (736-7348)
email us
Browse our resources

Who we are

Senseonics, Incorporated is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease.

Eversense Diabetes Website

Eversense USA Eversense OUS

FooterMenu Coloum second

Why Eversense CGM?

FooterMenu Coloumn third

EDUCATION & RESOURCES

Become a Provider footer

BECOME A PROVIDER
Login to DMS

DISCLAIMER

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otheiwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MKT-5143-01-001 Rev 2

Footer menu

© 2019 Senseonics, Incorporated
EULA
Privacy Policy
Legal
Safety
Contact Us
Site Map